作者
Jiang-Hui Wang, Rong Wang, Jia Hui Lee, Tiara WU Iao, Xiao Hu, Yu-Meng Wang, Lei-Lei Tu, Yi Mou, Wen-Li Zhu, Ai-Yong He, Shen-Yu Zhu, Di Cao, Lei Yang, Xiao-Bo Tan, Qing Zhang, Guan-Lu Liang, Shu-Min Tang, Ye-Di Zhou, Li-Jun Feng, Li-Jun Zhan, Nan-Nan Tian, Ming-Jie Tang, Ya-Ping Yang, Moeen Riaz, Peter van Wijngaarden, Gregory J Dusting, Guei-Sheung Liu, Yan He
发表日期
2017/9/15
来源
Molecular Therapy-Methods & Clinical Development
卷号
6
页码范围
40-42
出版商
Elsevier
简介
Gene therapy, a medical procedure that delivers genetic materials into a person to potentially prevent or treat disease at its genetic roots, has long fascinated scientists, clinicians, and the general public. Although gene therapy has a checkered history, with several prominent adverse events in early trials, significant safety and efficacy improvements in the last two decades have catapulted the technology back to the center stage of medical research. As gene therapy rapidly progresses toward widespread clinical use, there is growing evidence of concern and skepticism in the scientific community and the general public alike. 1 Among a range of concerns about gene therapy, balancing the benefits and risks of gene therapy stands out as a recurring theme. Ethical debate over the use of gene therapy for non-medical purposes, such as genetic enhancement of intelligence or physical aesthetics, has been robust. In …
引用总数
2019202020212022202320246413773
学术搜索中的文章
JH Wang, R Wang, JH Lee, TWU Iao, X Hu, YM Wang… - Molecular Therapy Methods & Clinical Development, 2017